Detalles de la búsqueda
1.
Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trial.
Lancet
; 402(10416): 1979-1990, 2023 11 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37898137
2.
Ultrathin-strut vs thin-strut drug-eluting stents for multi and single-stent lesions: A lesion-level subgroup analysis of 2 randomized trials.
Am Heart J
; 263: 73-84, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37192697
3.
Complex primary percutaneous coronary intervention with ultrathin-strut biodegradable versus thin-strut durable polymer drug-eluting stents in patients with ST-segment elevation myocardial infarction: A subgroup analysis from the BIOSTEMI randomized trial.
Catheter Cardiovasc Interv
; 101(4): 687-700, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36807456
4.
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial.
Lancet
; 394(10205): 1243-1253, 2019 10 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31488372
5.
Five-year clinical outcomes and intracoronary imaging findings of the COMFORTABLE AMI trial: randomized comparison of biodegradable polymer-based biolimus-eluting stents with bare-metal stents in patients with acute ST-segment elevation myocardial infarction.
Eur Heart J
; 40(24): 1909-1919, 2019 06 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30851032
6.
Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial.
Lancet
; 392(10149): 737-746, 2018 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30170848
7.
Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study.
Am Heart J
; 209: 97-105, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30703644
8.
Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial.
Lancet
; 384(9960): 2111-22, 2014 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-25189359
9.
Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial.
JAMA
; 308(8): 777-87, 2012 Aug 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-22910755
10.
Five-Year Outcomes With Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients With Acute Coronary Syndrome: A Subgroup Analysis of the BIOSCIENCE Trial.
Cardiovasc Revasc Med
; 34: 3-10, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33653633
11.
A prospective, multicentre first-in-man study of the polymer-free ultrathin-strut BIOrapid stent (BIOVITESSE).
EuroIntervention
; 18(2): e132-e139, 2022 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34794936
12.
Outcomes and regional differences in practice in a worldwide coronary stent registry.
Heart
; 108(16): 1310-1318, 2022 07 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35012960
13.
Abbreviated Antiplatelet Therapy After Coronary Stenting in Patients With Myocardial Infarction at High Bleeding Risk.
J Am Coll Cardiol
; 80(13): 1220-1237, 2022 09 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36137672
14.
Multivessel percutaneous coronary intervention with thin-strut biodegradable versus durable polymer drug-eluting stents in ST-segment elevation myocardial infarction: A subgroup analysis of the BIOSTEMI randomized trial.
Int J Cardiol
; 334: 37-41, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33887341
15.
Biodegradable- Versus Durable-Polymer Drug-Eluting Stents for STEMI: Final 2-Year Outcomes of the BIOSTEMI Trial.
JACC Cardiovasc Interv
; 14(6): 639-648, 2021 03 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33727005
16.
One-year performance of thin-strut cobalt chromium sirolimus-eluting stent versus thicker strut stainless steel biolimus-eluting coronary stent: a propensity-matched analysis of two international all-comers registries.
Coron Artery Dis
; 32(5): 391-396, 2021 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33060529
17.
Exclusion of a coronary aneurysm with a polyurethane-covered stent.
Turk Kardiyol Dern Ars
; 47(7): 609-611, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31582669
18.
Five-Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents.
J Am Heart Assoc
; 8(22): e013607, 2019 11 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31696762
19.
A comparison of an ultrathin-strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the BIOSTEMI trial.
EuroIntervention
; 14(6): 692-699, 2018 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-29205157
20.
Orsiro cobalt-chromium sirolimus-eluting stent: present and future perspectives.
Expert Rev Med Devices
; 14(10): 773-788, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28889769